Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives

Acute myeloid leukemia (AML) is a heterogeneous disease characterized by remarkable toxicity and great variability in response to treatment. Plenteous pharmacogenetic studies have already been published for classical therapies, such as cytarabine or anthracyclines, but such studies remain scarce for...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto-Merino, Álvaro, Labrador, Jorge, Zubiaur, Pablo, Alcaraz, Raquel, Herrero, María José, Montesinos, Pau, Abad-Santos, Francisco, Saiz-Rodríguez, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954545/
https://www.ncbi.nlm.nih.gov/pubmed/35335935
http://dx.doi.org/10.3390/pharmaceutics14030559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954545/
https://www.ncbi.nlm.nih.gov/pubmed/35335935
http://dx.doi.org/10.3390/pharmaceutics14030559

Ejemplares similares